What is Delcath Systems's clinical trial expenses?

Delcath Systems (DCTH) reported clinical trial expenses of $2.45M in Q1 2026.

How has Delcath Systems's clinical trial expenses changed year-over-year?

Delcath Systems's clinical trial expenses increased by 102.6% year-over-year, from $1.21M to $2.45M.

What is the long-term trend for Delcath Systems's clinical trial expenses?

Over 4 years (2021 to 2025), Delcath Systems's clinical trial expenses has grown at a 10.2% compound annual growth rate (CAGR), from $1.63M to $2.41M.

Delcath Systems DCTH Clinical trial expenses

Other financials

Income statement

See full

Revenue$25.0M+26.3%

Gross profit$21.3M+25.5%

Operating income-$1.6M-355%

Net income-$1.1M-200%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$41.3M+223%

Total debt$907.0K-10.7%

Total equity$112.7M+40.5%

Total assets$124.8M+43.0%

Cash flow

See full

Operating cash flow$857.0K-61.1%

CapEx$570.0K+307%

Free cash flow$287.0K-86.1%

Valuation

See full

Market cap$425.31M-11.8%

Enterprise value$384.91M-18.2%

P/E120.6×—

P/S4.7×-4.3×

Profitability

See full

Gross margin86%+1.1pp

Operating margin-118.1%-56.8pp

Net margin1.5%+0.8pp

FCF margin21.2%+15.2pp

Returns & leverage

See full

Return on equity1.9%+1.0pp

Debt / equity0×0.0×

Current ratio11.2×-4.7×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept dcth:PrepaidClinicalTrialExpensesCurrent.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's clinical trial expenses.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Delcath Systems's clinical trial expenses?: Delcath Systems (DCTH) reported clinical trial expenses of $2.45M in Q1 2026.
How has Delcath Systems's clinical trial expenses changed year-over-year?: Delcath Systems's clinical trial expenses increased by 102.6% year-over-year, from $1.21M to $2.45M.
What is the long-term trend for Delcath Systems's clinical trial expenses?: Over 4 years (2021 to 2025), Delcath Systems's clinical trial expenses has grown at a 10.2% compound annual growth rate (CAGR), from $1.63M to $2.41M.